Reviews Ofatumumab Injection


No reviews yet.

Arzerra Drug Description
ARZERRA
(ofatumumab) Injection, for Intravenous Infusion
DRUG DESCRIPTION
ARZERRA (ofatumumab) is an IgG1κ human monoclonal antibody with a molecular weight of approximately 149 kDa. The antibody was generated via transgenic mouse and hybridoma technology and is produced in a recombinant murine cell line (NS0) using standard mammalian cell cultivation and purification technologies.
ARZERRA is a sterile, colorless, preservative-free liquid concentrate for intravenous administration. ARZERRA is supplied at a concentration of 20 mg/mL in 10 mL single-use vials. Each single-use vial contains 100 mg ofatumumab in 5 mL of solution. Inactive ingredients include: 8.55 mg/mL sodium citrate and 0.195 mg/mL citric acid monohydrate as buffering agents, 5.85 mg/mL sodium chloride as an isotonic agent, and Water for Injection, USP as the solvent. The pH is 6.5.
Last reviewed on RxList: 11/5/2009




Arzerra Drug Description
ARZERRA
(ofatumumab) Injection, for Intravenous Infusion
DRUG DESCRIPTION
ARZERRA (ofatumumab) is an IgG1κ human monoclonal antibody with a molecular weight of approximately 149 kDa. The antibody was generated via transgenic mouse and hybridoma technology and is produced in a recombinant murine cell line (NS0) using standard mammalian cell cultivation and purification technologies.
ARZERRA is a sterile, colorless, preservative-free liquid concentrate for intravenous administration. ARZERRA is supplied at a concentration of 20 mg/mL in 10 mL single-use vials. Each single-use vial contains 100 mg ofatumumab in 5 mL of solution. Inactive ingredients include: 8.55 mg/mL sodium citrate and 0.195 mg/mL citric acid monohydrate as buffering agents, 5.85 mg/mL sodium chloride as an isotonic agent, and Water for Injection, USP as the solvent. The pH is 6.5.
Last reviewed on RxList: 11/5/2009




Arzerra Drug Description
ARZERRA
(ofatumumab) Injection, for Intravenous Infusion
DRUG DESCRIPTION
ARZERRA (ofatumumab) is an IgG1κ human monoclonal antibody with a molecular weight of approximately 149 kDa. The antibody was generated via transgenic mouse and hybridoma technology and is produced in a recombinant murine cell line (NS0) using standard mammalian cell cultivation and purification technologies.
ARZERRA is a sterile, colorless, preservative-free liquid concentrate for intravenous administration. ARZERRA is supplied at a concentration of 20 mg/mL in 10 mL single-use vials. Each single-use vial contains 100 mg ofatumumab in 5 mL of solution. Inactive ingredients include: 8.55 mg/mL sodium citrate and 0.195 mg/mL citric acid monohydrate as buffering agents, 5.85 mg/mL sodium chloride as an isotonic agent, and Water for Injection, USP as the solvent. The pH is 6.5.
Last reviewed on RxList: 11/5/2009




Arzerra Drug Description
ARZERRA
(ofatumumab) Injection, for Intravenous Infusion
DRUG DESCRIPTION
ARZERRA (ofatumumab) is an IgG1κ human monoclonal antibody with a molecular weight of approximately 149 kDa. The antibody was generated via transgenic mouse and hybridoma technology and is produced in a recombinant murine cell line (NS0) using standard mammalian cell cultivation and purification technologies.
ARZERRA is a sterile, colorless, preservative-free liquid concentrate for intravenous administration. ARZERRA is supplied at a concentration of 20 mg/mL in 10 mL single-use vials. Each single-use vial contains 100 mg ofatumumab in 5 mL of solution. Inactive ingredients include: 8.55 mg/mL sodium citrate and 0.195 mg/mL citric acid monohydrate as buffering agents, 5.85 mg/mL sodium chloride as an isotonic agent, and Water for Injection, USP as the solvent. The pH is 6.5.
Last reviewed on RxList: 11/5/2009




Arzerra Drug Description
ARZERRA
(ofatumumab) Injection, for Intravenous Infusion
DRUG DESCRIPTION
ARZERRA (ofatumumab) is an IgG1κ human monoclonal antibody with a molecular weight of approximately 149 kDa. The antibody was generated via transgenic mouse and hybridoma technology and is produced in a recombinant murine cell line (NS0) using standard mammalian cell cultivation and purification technologies.
ARZERRA is a sterile, colorless, preservative-free liquid concentrate for intravenous administration. ARZERRA is supplied at a concentration of 20 mg/mL in 10 mL single-use vials. Each single-use vial contains 100 mg ofatumumab in 5 mL of solution. Inactive ingredients include: 8.55 mg/mL sodium citrate and 0.195 mg/mL citric acid monohydrate as buffering agents, 5.85 mg/mL sodium chloride as an isotonic agent, and Water for Injection, USP as the solvent. The pH is 6.5.
Last reviewed on RxList: 11/5/2009





Other reviews about Ofatumumab Injection on wordpress

Today's Top Three in Pharma 060109
  by Steve Woodruff
Novartis' Reclast gets approval for osteoporosis prevention in post-menopausal women - Reclast® (zoledronic acid 5 mg) Injection[*] has been approved by the US Food and Drug Administration (FDA) […]


GlaxoSmithKline - Products
  by El Horror
About - Every second: Distributes more than 35 doses of vaccine. - Every minute: More than 1,100 prescriptions are written for GSK products. - Every hour: Spends more than $562,000 to […]


What Are Biologic Response Modifiers?
  by WarmSocks
Think back to high school chemistry classes.  I remember making peanut brittle to learn about double-bonds, making ice cream to drive home the point that salt affects the […]



Other reviews about Ofatumumab Injection on web:

Ofatumumab injection is used to treat chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells) in adults who have not gotten better after treatment with ... Ofatumumab Injection: MedlinePlus Drug Information


Ofatumumab (Injection) ... You should not receive this medicine if you have had an allergic reaction to ofatumumab. St. Luke's Sugar Land Hospital - Your Health Topics


Ofatumumab (Injection) ... You should not receive this medicine if you have had an allergic reaction to ofatumumab. Kelsey-Seybold Clinic - Welcome


Ofatumumab (Injection) ... You should not receive this medicine if you have had an allergic reaction to ofatumumab. Health and Drug Information


Learn about the prescription medication Arzerra (Ofatumumab Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Arzerra (Ofatumumab Injection) Drug Information: Uses, Side ...


Ofatumumab (oh-FAT-oo-moo-mab) Treats chronic lymphocytic leukemia (CLL). This medicine is given to patients who have already received other cancer medicines (such as alemtuzumab or ... Ofatumumab (Injection) - Central Baptist


Ofatumumab (oh-FAT-oo-moo-mab) Treats chronic lymphocytic leukemia (CLL). This medicine is given to patients who have already received other cancer medicines (such as alemtuzumab or ... Ofatumumab (Injection) - Avera Health


HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA ARZERRA (ofatumumab) Injection, for intravenous infusion ...


How is ofatumumab given? Ofatumumab is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting. Providence Health & Services - ofatumumab


Get information on how Ofatumumab Injection is used, including different forms of the medication and how they should be taken. Learn about Ofatumumab Injection from Consumer Reports Health.





Featured Reviews

Reviews Truvada

Truvada Drug Description TRUVADA® (emtricitabine/tenofovir disoproxil fumarate) Tablets WARNINGS: LACTIC ACIDOSIS/SEVERE HEPATOMEGALY WITH STEATOSIS and POST TREATMENT ACUTE EXACERBATION OF HEPATITIS B Lactic acidosis and...
Read More  |  Review This
Reviews Guanethidine Monosulfate

Ismelin Drug Description DRUG DESCRIPTION What are the possible side effects of guanethidine (Ismelin)? If you experience any of the following serious side effects, stop taking guanethidine and seek emergency medical attention...
Read More  |  Review This
Reviews Noxafil

Noxafil Drug Description NOXAFIL® (posaconazole) Oral suspension DRUG DESCRIPTION What are the possible side effects of posaconazole (Noxafil)? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Reviews Premarin Injection

Premarin Injection Drug Description Premarin®Intravenous (conjugated estrogens, USP) for Injection Specially prepared for Intravenous & Intramuscular use WARNINGS ENDOMETRIAL CANCER Adequate diagnostic measures, including...
Read More  |  Review This
Reviews Mebaral

Mebaral Drug Description MEBARAL® (mephobarbital) Tablets, USP DRUG DESCRIPTION What are the possible side effects of mephobarbital (Mebaral)? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....